Clinical Trial Update: Clinical Study Protocol of Venetoclax Combined With Azacitidine and Harringtonine in the Treatment of sAML [Phase 2]

View source ↗

Summary

Phase 2 clinical study protocol evaluating venetoclax with azacitidine and harringtonine for secondary acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Venetoclax (venetoclax)
• harringtonine (harringtonine)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Secondary Acute Myeloid Leukemia | Phase 2 | Status: UNKNOWN